Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes
for
Intra-amniotic Infection
Location: Cincinnati OH, Indianapolis IN, Louisville KY,
Sponsor: ProteoGenix, Inc.
Sex: Female
Age: 18+
Code: NCT00700219
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Cincinnati OH, Louisville KY, Canton OH, Cleveland OH,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
A Study of PYX-201 in Advanced Solid Tumors
for
Solid Tumor, Advanced Solid Tumor
Location: Cincinnati OH, Chicago IL, St Louis MO, Fairfax VA,
Sponsor: Pyxis Oncology, Inc
Sex: All
Age: 18+
Code: NCT05720117
Phase1, Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
for
Metastatic Non Small Cell Lung Cancer
Location: Cincinnati OH, Columbus OH, Louisville KY, Detroit MI,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT04614103
Phase2, Recruiting
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Cincinnati OH, Columbus OH, Fort Wayne IN,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase3, Recruiting
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
for
Hematological Malignancy, Solid Tumor Malignancy
Location: Cincinnati OH, Charlotte NC, Baltimore MD, Seattle WA
Sponsor: Century Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05768269
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%